Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FLT3 mutations as diagnostic and prognostic biomarkers in acute myeloid leukemia.

Clinica chimica acta; international journal of clinical chemistry - 15 Sept 2026

Thapa Riya, Fuloria Neeraj Kumar, Bhat Asif Ahmad, Porwal Omji, Ansari Mohammed Tahir, Narain Kamal, Biswas Anupam, Biswas Sangita, Bhatia Sumita, Fuloria Shivkanya

Abstract excerpt

Acute myeloid leukemia (AML) is a diverse and complex haematological cancer that cannot be fully characterized, even with the combination of morphology and cytogenetics. As a result, molecular biomarkers have become the focus of diagnosis, risk stratification, therapeutic planning and monitoring of disease. Of these, FLT3 mutations have been identified as being clinically relevant, clinically important, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to fms-Like Tyrosine Kinase 3

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ELN gene

Share to FLT3 gene

Share to Leukemia, Myeloid, Acute

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 42235731
DOI: 10.1016/j.cca.2026.121132

Genes

FLT3
ELN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 15 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FLT3 mutations as diagnostic and prognostic biomarkers in acute myeloid leukemia.PMID 42235731Read ↗

FLT3 mutational analysis in acute myeloid leukemia: Advantages and pitfalls with different approaches.Semantic proximity Read ↗

FLT3 Mutations in Acute Myeloid Leukemia: Unraveling the Molecular Mechanisms and Implications for Targeted TherapiesSemantic proximity Read ↗

Current knowledge about FLT3 gene mutations, exploring the isoforms, and protein importance in AML.Semantic proximity Read ↗

Role of Biomarkers in FLT3 AMLSemantic proximity Read ↗

Targeting FLT3 mutations in AML: review of current knowledge and evidenceSemantic proximity Read ↗

Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments.Semantic proximity Read ↗

The importance of FLT3 mutational analysis in acute myeloid leukemiaSemantic proximity Read ↗

FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm.Semantic proximity Read ↗

The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.Semantic proximity Read ↗

Molecular diagnostics of acute myeloid leukemia: it's a (next) generational thing.Semantic proximity Read ↗

An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape.Semantic proximity Read ↗

Revisiting the prognostic role of FLT3 mutations in acute myelogenous leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.